The aberrant metabolism of amyloid-b protein (Ab) in the human brain has been implicated in the etiology of Alzheimer disease (AD). c-Secretase is the enzyme that generates various forms of Ab, such as Ab40 and Ab42, the latter being an aggregation-prone toxic peptide that is involved in the pathogenesis of AD. Recently, we found that clathrin-mediated endocytosis of c-secretase affects the production and deposition of Ab42 in vivo, suggesting that the membrane trafficking of c-secretase affects its enzymatic activity. However, the detailed intracellular trafficking pathway of c-secretase and its contribution to Ab42 generation remain unclear. Here, we show that Retro-2, which inhibits the retrograde transport, elevated the Ab42-generating activity both in cultured cells and mice brain. However, the result of in vitro c-secretase assay using a recombinant substrate suggested that Retro-2 did not elevate the intrinsic Ab42-production activity of csecretase. Immunocytochemistry and cell-surface biotinylation experiments revealed that c-secretase is recycled via the endosome-to-trans-Golgi network transport. In addition, csecretase is retrogradely transported by syntaxin 5/6, known as targets of Retro-2, independent pathway. Conversely, TPT-260, which enhances the trafficking function of retromers, lowered Ab42 levels and the Ab42/(Ab40 + Ab42) ratio in secreted Ab from cultured cells. Our results strongly suggest that the endosome-to-trans-Golgi network trafficking of csecretase regulates its Ab42 production activity. Modulation of this trafficking pathway might be a potential target for the development of Ab42-lowering AD therapeutics.
The aggregation and deposition of amyloid-b peptide (Ab) in the human brain underlies the pathogenesis of Alzheimer disease (AD). Ab is derived from amyloid b-precursor protein (APP) through sequential proteolytic cleavage by b-and csecretases (Holtzman et al. 2011; De Strooper and Karran 2016) . c-Secretase is an intramembrane-cleaving protease comprising presenilin (PS; the catalytic subunit), nicastrin (Nct), anterior pharynx-defective 1, and presenilin enhancer 2 (Takasugi et al. 2003) . Cleavage of APP by c-secretase takes place at multiple sites within the transmembrane domain sequence to generate various types of Ab with different Cterminal lengths, and Ab40 is the major generated form (Tomita 2014) . Ab42 is the most aggregation-prone and initially deposited species in AD brains (Iwatsubo et al. 1994) . Several genetic studies have demonstrated that many mutations in genes encoding APP and PS, which are linked to autosomal-dominant familial AD, cause an increase in the Ab42/total Ab ratio that is a ratio of proportion Ab42 in total Ab production. Thus, these studies implicate an important role of brain Ab42 levels in the pathogenesis of AD.
Several lines of evidence suggest that membrane trafficking plays a crucial role in Ab production (Thinakaran and Koo 2008; Rajendran and Annaert 2012; Morohashi and Tomita 2013) . Moreover, genome-wide association studies of late-onset AD patients have identified several genetic risks/protective factors for AD that are associated with membrane trafficking, including phosphatidylinositol-binding clathrin assembly protein (Harold et al. 2009; Seshadri et al. 2010; Lambert et al. 2013) , strongly suggesting that this process is closely involved in the etiology of AD. Notably, the efficient b-cleavage of APP by b-site amyloid precursor protein cleaving enzyme 1 (BACE1) requires clathrin-dependent endocytosis (Perez et al. 1999 ). In contrast, the detailed subcellular localization of, as well as the relationship between the subcellular localization and enzymatic activity of c-secretase have been enigmatic (Morohashi and Tomita 2013) . Recently, we have shown that loss of CALM, which is encoded by the PICALM gene, selectively reduces the Ab42/(Ab40 + Ab42) ratio, and ameliorates amyloid deposition (Kanatsu et al. 2014) . CALM regulates clathrin-mediated endocytosis and the lysosomal localization of c-secretase, which correlate with the up-regulation of Ab42-generating activity. However, other intracellular trafficking pathways of c-secretase as well as the effect of such trafficking pathways on the enzymatic activity of c-secretase have remained unclear. In this study, we show that the endosome-to-trans-Golgi network (TGN) retrograde transport of c-secretase regulates the Ab42/(Ab40 + Ab42) ratio in vitro and in vivo. Our results suggest that retrieval of the csecretase complex from late endosomes/lysosomes antagonizes the development of AD by reducing Ab42 production.
Methods

Antibodies and chemicals
The following antibodies were purchased from commercial suppliers: anti-APPc (RRID:AB_494473; #18961; Immuno-Biological Laboratories, Fujioka, Gunma, Japan, 1 : 1000 dilution), anti-sAPPa (RRID:AB_2341463; #28055; Immuno-Biological Laboratories, 1 : 1000 dilution), anti-sAPPb (RRID:AB_1630824; #18957; Immuno-Biological Laboratories, 1 : 100 dilution), anti-human Ab specific antibody 82E1 (RRID:AB_1630806; #10323; ImmunoBiological Laboratories, 1 : 1000 dilution), anti-BACE1 (RRID: AB_494477; #18711; Immuno-Biological Laboratories, 1 : 1000 dilution), anti-a-tubulin DM1A (RRID:AB_477583; T6199; Sigma, St Louis, MO, USA, 1 : 2000 dilution), anti-Nct (RRID: AB_477259; N1660; Sigma, 1 : 1000 dilution), anti-early endosome antigen 1 (RRID:AB_2096814; #2411S; Cell Signaling Technology, Danvers, MA, USA, 1 : 200 dilution), anti-vacuolar protein sortingassociated protein 35 (VPS35) (RRID:AB_2215211; EB06268; Everest Biotech, Upper Heyford, Oxfordshire, UK 1 : 250 dilution), anti-TGN46 (RRID:AB_323104; AHP500G; Bio-Rad Laboratories, Hercules, CA, USA, 1 : 500 dilution), anti-Syntaxin 5 (#14151; Cell Signaling Technology, 1 : 1000 dilution), anti-Syntaxin 6 (RRID: AB_397965; #610635; BD Transduction Laboratories, Franklin Lakes, NJ, USA 1 : 1000 dilution). Mouse monoclonal anti-Nct A5226A was described previously (Hayashi et al. 2012) . Pitstop 2 (#ab120687) and Iminodyn 22 (#ab120461) were purchased from Abcam, Cambridge, UK. Retro-2 (#554715) and TPT-260 (#16079) were purchased from Calbiochem, San Diego, CA, USA and Cayman Chemical, Ann Arbor, MI, USA respectively. All compounds were dissolved in dimethyl sulfoxide (DMSO).
Cell culture and plasmid transfection HeLa S3 [RRID:CVCL_0058; #CCL-2.2; American Type Culture Collection (ATCC), Manassas, VA, USA] and Neuro2a (N2a) (RRID:CVCL_0470; #CCL-131; ATCC) cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. These cell lines are not listed by International Cell Line Authentication Committee (ICLAC). Contamination was routinely tested by DNA staining. Expression constructs encoding full-length wild-type human APP 695 have been described before (Iwata et al. 2001) . For CRISPR/Cas9 system, pSpCas9(BB)-2A-GFP (PX458) and eSpCas9(1.1) were gifted from Dr. Feng Zhang (Addgene number 48138 and 71814, respectively). We replaced the SpCas9 in PX 458 to eSpCas9(1.1) to construct peSpCas9(1.1)(BB)-2A-GFP. sgRNAs were designed using the web tools provided by ATUM (https://www.atum.bio/eCommerce/cas9/input). sgRNA sequences targeting murine syntaxin 5/6 were (TAGATCCG-TAGCGTTTCCGC, GGATATTGATGGTTTCATCG) cloned into the plasmid peSpCas9(1.1)(BB)-2A-GFP. To generate knock-out monoclonal cell lines, cell suspension was placed into 96-well plate after transfection and limited dilution. Compounds were treated 24 h before sample collection. In case of analysis of secreted Ab, compound treatment was conducted in parallel with medium change. In experiments in which a combination of siRNA/plasmid delivery and compound treatment was necessary, siRNA were transfected by mixing 6 pmol RNAi duplex (5 0 -GUGUGGACUAC- For immunocytochemical analysis, cells cultured on glass coverslips were fixed for 15 min in 4% paraformaldehyde and then permeabilized with 0.2% Triton X-100 for 10 min. All solutions were made in Phosphate buffered saline (PBS). Coverslips were then incubated with primary antibodies as indicated for 1 h. After washing with PBS, coverslips were incubated with secondary antibodies for 1 h and washed with PBS, and mounted on glass slides using PermaFluor Aqueous Mounting Medium (Thermo Fisher Scientific, Waltham, MA, USA) mixed with 1 lg/mL DAPI (4 0 ,6-diamidino-2-phenylindole) for nuclear staining. Images were collected using a fluorescence microscope (AxioObserver Z1; Zeiss, Oberkochen, Germany) with a 940 Plan Apochromat oil immersion objective of NA 1.3 and AxioVision software, or confocal microscopy (SP5; Leica, Wetzlar, Germany) with a 963 PL Apochromat for confocal scanning objective of NA 1.4 and LAS AF software (GE healthcare, Chicago, IL, USA). Images were cropped and processed using ImageJ software (NIH, Bethesda, MD, USA) and Huygens (Scientific Volume Imaging, Hilversum, The Netherlands). The ligand uptake assay using A5226A and the cell surface biotinylation experiment were performed as previously described (Kanatsu et al. 2014) . For western blot analyses, cells were lysed in Laemlli sample buffer and sonicated (Tomita et al. 1997) . Protein concentrations were measured using the bicinchoninic acid protein assay (#23227; Thermo Fisher Scientific, Waltham, MA, USA).
Ligand uptake assay Subconfluent HeLa cells were incubated in the medium containing 10 lg/mL anti-Nct MAb A5226A for 20 min at 37°C. After washing with medium, fresh pre-warmed medium was added and further incubated for 60 min at 37°C. Cells were then washed immediately with PBS, fixed in 4% paraformaldehyde/PBS (PFA) and processed for immunocytochemical analysis.
Ethics approval and animals
All animal experimental procedures were performed in accordance with the guidelines for animal experiments of The University of Tokyo, and were approved by the Institutional Animal Care and Use Committee/ethics committee of the Graduate School of Pharmaceutical Sciences, The University of Tokyo (protocol no. P25-6). All efforts were made to minimize animal suffering including less surgical stress (small incision and negligible bleeding). Animals were anesthetized using sodium pentobarbital (50 mg/kg, i.p. injection). The time of day at which the experiments were conducted was not specified. This study was not pre-registered. Six-week old wild-type female mice (C57B6/JJmsSlc; RRID: IMSR_JAX:000664; weighing approximately 15-18 g) were purchased from Japan SLC, Inc. Animals were housed in standard controlled environment with a 12 h light/dark cycle and had ad libitum access to food and water.
Brain lysate extraction 6-week old wild-type female mice were allocated into two groups (control and Retro-2, 4 mice each group). Pseudo randomization was performed based on an online tool (https://www.graphpad.com/ quickcalcs/). Hippocampi that were excised from 6-week old wildtype female mice injected with DMSO or Retro-2 were homogenized in radio-immunoprecipitation assay (RIPA) buffer (#89900; Thermo Scientific) containing cOmplete protease inhibitor cocktail (#11836145001; Roche Applied Science, Penzberg, Germany). Homogenates were cleared by centrifugation at 200 000 g for 20 min at 4°C, and the resultant supernatant was collected as the brain ristocetin-induced platelet agglutination fraction. Injection of compound was performed as described previously (Hori et al. 2015) with slight modification. Briefly, 2.5 lL of Retro-2 (20 lM) or DMSO solution was injected at 0.5 lL/min into the dentate gyrus (AP: À2.0 mm from bregma, ML: AE1.5 mm from midline, DV: À1.9 mm below brain surface) in 6-week-old wild-type mice anesthetized with sodium pentobarbital. Injected compound was prepared with less than 0.1% DMSO which was diluted with PBS. Then mice were returned to their home cage, and 6 h after the injection, hippocampi were excised from these mice. These extracts were used for quantitation of Ab by two-site enzyme-linked immunosorbent assay (ELISA); Human/Rat b-Amyloid (40) ELISA Kit (#294-62501; WAKO Pure Chemical Industries, Osaka, Japan) and Human/Rat b-Amyloid (42) ELISA Kit, High Sensitivity (#292-64501; WAKO Pure Chemical Industries). We did not exclude animals in this study.
Detection of Ab levels
For the quantitation of secreted Ab levels, conditioned media from N2a cells (na€ ıve or transiently expressing human APP 695 ) were analyzed by ELISA (Tomita et al. 1997) . For the measurement of human Ab1-40 and Ab1-42, human b Amyloid (1-40 and 1-42) ELISA Kit (#292-62301 for Ab1-40 and # 298-62401 for Ab1-42; WAKO) were used as the protocol of manufacturer. Ab levels were then standardized by protein concentrations of the cell lysates. For western blot analysis, secreted human Ab was separated on a ureasodium dodecyl sulfate-polyacrylamide gel electrophoresis gel and detected by western blotting using the human Ab-specific antibody 82E1 (Ohki et al. 2011) . In vitro c-secretase assays were performed as previously described, and de novo Ab was measured by ELISA (Kanatsu et al. 2014) .
Statistical analysis
In the in vitro experiments using cells, no randomization was performed. Sample sizes were based on previous studies (Kanatsu et al. 2014 ) in which we were able to identify statistically significant results. Data analyses were carried out from independent animals/ cells and were not conducted in a blinded fashion. We excluded samples only when there was evidence of contamination, cell peeling, or cell death prior to the experiments. R version 3.3.2 was used to perform statistical analysis.
Data are presented as mean values and error bars indicate the standard error of the mean (SEM). The treatment groups were compared by the two-tailed Student t-test. A p-value of less than 0.05 was considered to indicate a statistically significant difference between two groups.
For the co-localization analyses based on immunocytochemistry, data were tested for normal distribution with a Shapiro-Wilk test. For non-parametric comparison, the treatment groups were compared by Brunner-Munzel test or Wilcoxon rank sum test after Levene's test for equality of variance.
Results
Retro-2 increased the Ab42/(Ab40 + Ab42) ratio via csecretase cleavage Recent advances in chemical biology have enabled the use of small compounds to analyze intracellular trafficking without genetic manipulation, which sometimes causes several problems, including compensation by other proteins/machineries (von Kleist and Haucke 2012) . As we were focusing on the clathrin-mediated endocytosis of c-secretase, we chose two compounds; Pitstop 2, a clathrin-mediated endocytosis-specific inhibitor (von Kleist et al. 2011) , and Iminodyn 22, an inhibitor of dynamin GTPase activity (Hill et al. 2010) . We have shown that Pitstop 2 causes accumulation of the active c-secretase complex, which is represented by the mature glycosylated form of nicastrin (mNct), in the same manner to that by CALM depletion (Kanatsu et al. 2014) . Moreover, the ratio of Ab42/(Ab40 + Ab42) secreted from N2a cells was significantly decreased in Pitstop 2-treated and Iminodyn 22-treated cells (Fig. 1a and b) , confirming the notion that the endocytic rate of c-secretase controls the Ab42 production ratio and the amount of cell surface c-secretase.
Next, we examined the effect of the intracellular trafficking after endocytosis on the Ab production, as we have shown that the inhibition of endosomal maturation decreases the Ab42/(Ab40 + Ab42) production ratio (Kanatsu et al. 2014) . Following endocytic uptake from the plasma membrane, internalized cargoes first reach early endosomes. Usually, cargoes are targeted for degradation by their transport to late endosomes and eventually to lysosomes. Alternatively, cargoes can undergo recycling to the plasma membrane. In addition to these pathways, a significant amount of attention is now being focused on a third transport mechanism called the retrograde pathway, by which cargoes are delivered to the Golgi and TGN. Intriguingly, Retro-2, which inhibits retrograde transport (Stechmann et al. 2010) , specifically increased the levels of Ab42 as well as the Ab42/ (Ab40 + Ab42) ratio (Fig. 1c and d) . In addition, the amount of mNct was significantly reduced in Retro-2-treated cells, whereas the amounts of BACE1, sAPPa, and sAPPb were almost comparable (Fig. 1e) . These results suggest that Retro-2 affects Ab42 production at the level of c-secretase cleavage.
With the concern of the concentration of Retro-2 used in this study, we also evaluated the EC50 of Retro-2. It has been reported to be 10-12 lM in HeLa cells (Shtanko et al. 2018) and the concentration utilized in the report where the authors found Retro-2 blocked the retrograde transport was 20 lM (Stechmann et al. 2010) . We observed no change in the increased Ab42/(Ab40 + Ab42) ratio under the Retro-2 treatment between HeLa cells and N2a cells (Figure S1a ), indicating that there was no significant difference in the response toward Retro-2 between HeLa and N2a cell. Moreover, the Ab42/(Ab40 + Ab42) ratio under the Retro-2 treatment in N2a cells showed dose dependency ( Figure S1b ). Taken together, these reports and our data support the validity of 20 lM Retro-2 treatment that we used in our study.
To elucidate the effect of Retro-2 on c-secretase cleavage further, we examined the proportions of the generated Ab species using the urea-sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel system. Ab40 and Ab42 are thought to be generated by the successive cleavage of csecretase (Ab49-Ab46-Ab43-Ab40 or Ab48-Ab45-Ab42-Ab38, respectively) (Qi-Takahara et al. 2005; Tomita 2014 ). Ab38 is derived from the additional C-terminal trimming of Ab42, which is regulated by an familial AD-linked mutation and small compounds called c-secretase modulators (GSMs). Interestingly, Retro-2 increased the generation of Ab42 accompanied by a decrease in that of Ab38 ( Fig. 2a and b) , suggesting that it associates with c-secretase cleavage, particularly Ab38/42-trimming activity. However, recent study has reported different Ab42/Ab40 ratios for Ab(1-x) and Ab'(11-x) (Siegel et al. 2017) , suggesting the possibility that the observed results in the Ab42/(Ab40 + Ab42) ratio are derived from changes in the production of Ab versus Ab' rather than a change in the Ab full-length profile itself. To exclude this possibility, we over-expressed wild-type human APP in N2a cells and measured the Ab levels using human Ab ELISA that only detects the full-length Ab(1-x). In good agreement with the result from human/rodent Ab ELISA ( Fig. 1c and d) , a significant increase in the Ab1-40/(Ab1-40 + Ab1-42) ratio in secreted Ab was observed (Figure S2a) , supporting the notion that the altered Ab42/ (Ab40 + Ab42) ratio in our findings are related to the change in c-secretase activity. We then injected Retro-2 into the brains of 6-week-old wild-type mice. As a control, less than 0.1% DMSO which was diluted with PBS was injected into the contralateral hemisphere. Intriguingly, Ab42 levels as well as Ab42/(Ab40 + Ab42) ratio in the soluble fraction of the brain lysates of mice injected with Retro-2 were significantly increased, whereas Ab40 levels were unchanged (Fig. 2c, d and e) . These results indicate that Retro-2 affects brain Ab42 levels in vivo.
Inhibition of endosome-to-TGN transport by Retro-2 increased Ab42 production
We previously demonstrated that GSMs directly target csecretase to alter its conformation and activity Ohki et al. 2011; Takeo et al. 2014) . To investigate whether Retro-2 directly affects the enzymatic activity of c-secretase similarly to these GSMs, we carried out an in vitro c-secretase assay using a recombinant substrate. However, we observed no increase in the de novo generated Ab42/(Ab40 + Ab42) ratio (Fig. 3a and b) , suggesting that Retro-2 did not elevate the intrinsic Ab42-production activity of c-secretase. Considering previous reports that the subcellular localization of c-secretase affected its proteolytic activity (Fukumori et al. 2006; Kanatsu et al. 2014) , Ab42 production might be regulated by the endosome-to-TGN transport of c-secretase. Moreover, the level of mNct was significantly decreased in the Retro-2-treated cells. These results led us to test the notion that csecretase is rescued from its degradation at lysosomes via the endosome-to-TGN retrograde transport pathway. By immunofluorescence analysis using the mouse monoclonal antibody A5226A against human mNct, we previously showed that the majority of active c-secretase was localized at late endosomes/lysosomes, whereas the localization of csecretase to other compartments, such as early endosomes, TGN, and plasma membrane was barely detected (Kanatsu et al. 2014) . However, A5226A-labeled c-secretase was partially localized in VPS35-positive organelles in Retro-2-treated HeLa cells, although this localization was not significantly increased compared to DMSO-treated cells (Fig. 4a) . These results suggest the possibility that csecretase is retrogradely transported via both retromerdependent pathway and the novel pathway inhibited by Retro-2. We further performed a cell surface biotinylation experiment and found that Retro-2 reduced the levels of cell surface as well as total mNct (Fig. 4b and c) , suggesting that retrograde endosome-to-TGN transport mediates the retrieval of c-secretase from the degradation pathway at late endosomes and lysosomes. In order to directly monitor the trafficking of c-secretase, we performed the chase experiment of surface labeled c-secretase using A5226A antibody as shown in the previous study (Kanatsu et al. 2014) . Notably, co-localization of A5226A and TGN46, a TGN marker, was observed after 60 min of chase period and a retromer stabilizer TPT-260 (mentioned below) increased this colocalization (Fig. 4d) , directly indicating that internalized csecretase is constitutively transported from endosomes to TGN.
Retro-2 causes the relocalization of syntaxin 5 and 6 and inhibits the syntaxin 5-dependent endosome-to-TGN retrograde transport pathway (Stechmann et al. 2010; Nonnenmacher et al. 2015) . To investigate whether Retro-2 affected the c-secretase-mediated Ab42 production in a syntaxin 5 or 6-dependent manner, we generated syntaxin 5 or 6 knock-out N2a cells by genome-editing using CRISPR-Cas9 system (Fig. 5a ). In these clones, syntaxin 5 or 6 were partially knocked out. However, Retro-2 treatment of these cells still elevated Ab42/(Ab40 + Ab42) production ratio (Fig. 5b, c and Figure S2b ). For further elucidation of this point, we also tested knockdown of VPS35, a retromer component. In accordance with the result that Retro-2 did not affect the proportion of c-secretase localized in VPS35-positive organelles (Fig. 4a) , regardless of the reduced protein levels of VPS35 (Figure S2c ), Retro-2 treatment elevated the Ab42/ (Ab40 + Ab42) ratio ( Figure S2d) . These results suggest that the effects of Retro-2 were independent of syntaxin 5/6 and retromer function.
TPT-260, a retromer-stabilizing pharmacological chaperone, has an inverse effect to Retro-2 on Ab42 production by csecretase c-Secretase located at late endosomes/lysosomes exhibited higher Ab42 production activity than c-secretase localized in other compartments. Thus, the enhanced retrieval of csecretase from late endosomes/lysosomes would lead to a decrease in the Ab42/(Ab40 + Ab42) production ratio. To analyze this possibility, we examined TPT-260, which was recently identified as a retromer-stabilizing pharmacological chaperone that enhances the trafficking function of retromers (Mecozzi et al. 2014) . We confirmed that TPT-260 treatment reduced sAPPb production without affecting the levels of APP nor BACE1. Notably, TPT-260 treatment caused a reduction not only in secreted Ab levels but the Ab42/ (Ab40 + Ab42) ratio (Fig. 6a and b) . Furthermore, the accumulation of mNct was also observed in TPT-260-treated cells ( Fig. 6c and d) . Considering the result, that TPT-260 treatment increased the co-localization of A5226A and TGN46 (Fig. 4d) , these data suggest that TPT-260 acts as a novel Ab42-lowering GSM targeting endosome-to-TGN retrograde transport. Collectively, these results strongly suggest that the rate of the endosome-to-TGN transport of c-secretase is closely associated with the production ratio of Ab42/(Ab40 + Ab42).
Discussion
We have previously demonstrated that CALM, a genetic protective factor for AD, regulates the clathrin-mediated endocytosis of c-secretase and that its depletion alters the localization of c-secretase, leading to a lowered Ab42/ (Ab40 + Ab42) ratio (Kanatsu et al. 2014) . To further elucidate the effect of the membrane trafficking pathway on Ab42 production by c-secretase, we took a pharmacological approach. We found that the endosome-to-TGN retrograde pathway, which is another retrieval pathway of membrane proteins from transport into late endosomes/ lysosomes, regulates Ab42 production in vitro and in vivo. Therefore, the Ab42-producing activity of c-secretase is thought to be closely associated with the subcellular compartment where it resides (Fig. 7) . In addition, the efficiency of endosome-to-TGN retrograde transport was strongly correlated with the Ab42/(Ab40 + Ab42) production ratio, suggesting that the regulation of this pathway is a plausible molecular target for AD. Our findings raise the possibility of the development of a novel GSM that targets the intracellular transport of c-secretase.
Our present results demonstrate that c-secretase is constitutively transported from endosomes to the TGN. To date, several retrograde pathways have been identified. Among them, retromer-dependent trafficking, which is facilitated by TPT-260 (Mecozzi et al. 2014) , plays a crucial role in the endosome-to-TGN retrograde transport of various cargoes (McKenzie et al. 2012; Lu and Hong 2014) . On the other hand, retrograde transport of some cargos is independent of retromer (Simonetti et al. 2017) . Moreover, several toxins and viruses are transported via syntaxin 5-dependent trafficking pathway, which is blocked by Retro-2. Previous cell biological studies suggested that these trafficking machineries recognize distinct cargoes, whereas some cargo proteins are transported by both retrograde transport systems (Stechmann et al. 2010; Nonnenmacher et al. 2015) . In this study, both Retro-2 and TPT-260 affected the amount of mNct as well as Ab42 generation by c-secretase. However, this action of Retro-2 was independent of syntaxin 5/6 and retromer. Considering our immunocytochemical analysis that the chase experiment of anti-mNct A5226A antibody which showed the co-localization of A5226A with TGN46 ( Fig. 4d) and previous studies demonstrating that PS interacts with VPS35 (Suga et al. 2004; Ueda et al. 2016) , c-secretase may be retrogradely transported, by both the retromer-mediated pathway and by the novel, syntaxin 5/6-independent pathway inhibited by Retro-2.
Notably, Retro-2 did not affect sAPPa, nor sAPPb, whereas TPT-260 caused a decrease not only in the level of secreted Ab but sAPPb level. This result suggests that, in addition to c-secretase, APP and/or BACE1 are transported from endosomes to the TGN via the retromer-mediated pathway. In fact, TPT-260 shifts the endosomal localization of APP and reduces Ab production in cultured neurons (Mecozzi et al. 2014) . In N2a cells, we also observed marked decrease in total Ab levels (similarly to Mecozzi et al.) under the higher concentration of TPT-260 treatment (data not shown). However, because of the considerable decrease in total Ab levels, the change in Ab42/ Fig. 7 Schematic depiction of the relationship between intracellular membrane trafficking and Ab42 production activity of c-secretase. cSecretase (green) is internalized by CALM (orange circle)-dependent clathrin-mediated endocytosis and transported to late endosomes/ lysosomes (Kanatsu et al. 2014) . In this study, we found that some of the endocytosed c-secretase is trafficked by retrograde transport via the endosome-to-trans-Golgi network (TGN) pathway and this recycling pathway regulates Ab42 production. These results imply that the Ab42-producing activity of c-secretase is closely associated with its subcellular compartment. The Ab42 production activity is indicated by the graded brown color. Mechanisms targeted by small compounds are shown in red (inhibition) or blue (activation).
(Ab40 + Ab42) ratio was masked in this condition. This suggests that an appropriate concentration of TPT-260 treatment might be necessary to observe the transport of csecretase which leads to the decrease in Ab42/ (Ab40 + Ab42) ratio. In addition, TPT-172, but not TPT-260, showed a greater effect on Ab reduction in human neurons differentiated from human induced pluripotent stem cells (Young et al. 2018) , suggesting that species/cell typespecific mechanisms also underlie in the regulation of retrograde transport. Importantly, SORL1, which is a genetic risk factor of AD as well as a retromer cargo, interacts with APP to regulate its endosome-to-TGN transport as well as regulates total Ab production (Willnow and Andersen 2013) . This indicates that retromer-dependent retrograde transport of APP mainly affects the total level of Ab, which is regulated by BACE1-mediated cleavage of APP. In contrast, Retro-2 treatment specifically increased the Ab42/(Ab40 + Ab42) production ratio in syntaxin 5 or 6 knock-out cells and VPS35 knock-down cells, suggesting that the novel membrane trafficking machinery of c-secretase which is syntaxin 5/6-and VPS35-independent regulates the C terminus of secreted Ab. Indeed, recent studies identified various proteins related to the endosome-to-TGN transport, including sorting nexins, small GTPases, Golgi Associated Retrograde Proteins complex, and SNAREs, that generate cargo selectivity (Saimani and Kim 2017) . Nevertheless, further analyses to understand the molecular mechanisms of the endosome-to-TGN transport of c-secretase will be important toward the comprehensive understanding of the intracellular trafficking system involved in Ab production. In summary, we have shown that c-secretase is recycled via its endosome-to-TGN retrograde transport, which is closely involved in the production of Ab42. This study reinforces the notion that the membrane trafficking of c-secretase plays a crucial role in regulation of the Ab42/(Ab40 + Ab42) production ratio, and is a potential target for the development of novel therapeutics against AD.
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